“Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study” (2025) Asian Journal of Pharmaceutical and Health Sciences, 15(3), pp. 3114–3121. doi:10.5530/ajphs.2025.15.83.